No association between omalizumab use and risk of cancer: a nationwide registry‐based cohort study. (1st April 2022) - Ali, Zarqa; Egeberg, Alexander; Thyssen, Jacob P.; Sørensen, Jennifer Astrup; Vestergaard, Christian; Thomsen, Simon Francis